NO942075L - Rekombinante virus omfattende kunstig proteolytisk spaltingssete - Google Patents
Rekombinante virus omfattende kunstig proteolytisk spaltingsseteInfo
- Publication number
- NO942075L NO942075L NO942075A NO942075A NO942075L NO 942075 L NO942075 L NO 942075L NO 942075 A NO942075 A NO 942075A NO 942075 A NO942075 A NO 942075A NO 942075 L NO942075 L NO 942075L
- Authority
- NO
- Norway
- Prior art keywords
- recombinant viruses
- cleavage site
- proteolytic cleavage
- replication
- viruses including
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title abstract 4
- 230000006337 proteolytic cleavage Effects 0.000 title 1
- 206010017533 Fungal infection Diseases 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002538 fungal effect Effects 0.000 abstract 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 241000897111 recombinant polioviruses Species 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80489391A | 1991-12-06 | 1991-12-06 | |
| US94779092A | 1992-09-18 | 1992-09-18 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO942075D0 NO942075D0 (no) | 1994-06-03 |
| NO942075L true NO942075L (no) | 1994-08-03 |
Family
ID=27122734
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO942075A NO942075L (no) | 1991-12-06 | 1994-06-03 | Rekombinante virus omfattende kunstig proteolytisk spaltingssete |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0672157B1 (fr) |
| JP (1) | JPH07502403A (fr) |
| KR (1) | KR100272419B1 (fr) |
| CN (1) | CN1055726C (fr) |
| AT (1) | ATE206762T1 (fr) |
| AU (1) | AU674134B2 (fr) |
| CA (1) | CA2123804A1 (fr) |
| CZ (1) | CZ127394A3 (fr) |
| DE (1) | DE69232122T2 (fr) |
| DK (1) | DK0672157T3 (fr) |
| ES (1) | ES2163405T3 (fr) |
| FI (1) | FI942623A (fr) |
| HU (1) | HUT67346A (fr) |
| IL (1) | IL104003A0 (fr) |
| MX (1) | MX9206981A (fr) |
| NO (1) | NO942075L (fr) |
| NZ (1) | NZ246276A (fr) |
| PT (1) | PT672157E (fr) |
| TW (1) | TW403784B (fr) |
| WO (1) | WO1993011251A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997012048A1 (fr) * | 1995-09-27 | 1997-04-03 | Medical Research Council | Virus recombines comprenant une proteine pouvant etre clivee par une protease |
| FI20075063A0 (fi) | 2007-02-01 | 2007-02-01 | Vactech Oy | Allergisen herkistymisen estäminen |
| AU2019237413A1 (en) * | 2018-03-19 | 2020-09-24 | Boehringer Ingelheim Vetmedica (China) Co., Ltd. | Recombinant virus capable of stably expressing target proteins |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1293591C (fr) * | 1985-01-11 | 1991-12-24 | Charles A. Kettner | Substrats peptidiques pour la detection de l'activite de la protease contre certains virus |
| EP0321973B1 (fr) * | 1987-12-23 | 1993-11-03 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Expression de la protéase P2A de HRV2 codée par un virus |
| DE68929521T2 (de) * | 1988-02-26 | 2006-02-23 | Large Scale Biology Corp., Vacaville | Nicht-nukleare chromosomale Transformation |
| DD275259A1 (de) * | 1988-08-30 | 1990-01-17 | Akad Wissenschaften Ddr | Verfahren zur konstruktion eines neuen expressionsvektors |
| WO1990011359A1 (fr) * | 1989-03-20 | 1990-10-04 | Whitehead Institute For Biomedical Research | Procede intracellulaire d'inhibition de l'hiv dans des cellules de mammiferes |
| GB8912496D0 (en) * | 1989-05-31 | 1989-07-19 | Medical Res Council | Vaccines |
| CA2055613A1 (fr) * | 1989-05-31 | 1990-12-01 | Jeffrey W. Almond | Chimeres de poliovirus |
| EP0867510A1 (fr) * | 1990-05-28 | 1998-09-30 | The Research Foundation For Microbial Diseases Of Osaka University | Procédé de préparation de plasmides ayant les capacités d'expression et de transformation après translation d'un gène de rétrovirus, plasmides ainsi obtenus, et leur produits d'expression |
| EP0497949A1 (fr) * | 1990-08-28 | 1992-08-12 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Systeme d'essai permettant de controler l'activite de proteinases virales |
-
1992
- 1992-12-03 MX MX9206981A patent/MX9206981A/es unknown
- 1992-12-04 KR KR1019940701920A patent/KR100272419B1/ko not_active IP Right Cessation
- 1992-12-04 EP EP93900925A patent/EP0672157B1/fr not_active Expired - Lifetime
- 1992-12-04 NZ NZ246276A patent/NZ246276A/en unknown
- 1992-12-04 AU AU32424/93A patent/AU674134B2/en not_active Ceased
- 1992-12-04 ES ES93900925T patent/ES2163405T3/es not_active Expired - Lifetime
- 1992-12-04 CZ CZ941273A patent/CZ127394A3/cs unknown
- 1992-12-04 HU HU9401689A patent/HUT67346A/hu unknown
- 1992-12-04 WO PCT/US1992/010543 patent/WO1993011251A1/fr active IP Right Grant
- 1992-12-04 DE DE69232122T patent/DE69232122T2/de not_active Expired - Fee Related
- 1992-12-04 CA CA002123804A patent/CA2123804A1/fr not_active Abandoned
- 1992-12-04 IL IL104003A patent/IL104003A0/xx unknown
- 1992-12-04 AT AT93900925T patent/ATE206762T1/de not_active IP Right Cessation
- 1992-12-04 DK DK93900925T patent/DK0672157T3/da active
- 1992-12-04 PT PT93900925T patent/PT672157E/pt unknown
- 1992-12-04 CN CN92115173A patent/CN1055726C/zh not_active Expired - Fee Related
- 1992-12-04 JP JP5510379A patent/JPH07502403A/ja active Pending
-
1993
- 1993-03-16 TW TW082101918A patent/TW403784B/zh not_active IP Right Cessation
-
1994
- 1994-06-03 NO NO942075A patent/NO942075L/no not_active Application Discontinuation
- 1994-06-03 FI FI942623A patent/FI942623A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK0672157T3 (da) | 2001-12-03 |
| HUT67346A (en) | 1995-03-28 |
| CZ127394A3 (en) | 1995-11-15 |
| AU3242493A (en) | 1993-06-28 |
| FI942623A (fi) | 1994-07-21 |
| EP0672157A1 (fr) | 1995-09-20 |
| WO1993011251A1 (fr) | 1993-06-10 |
| CN1055726C (zh) | 2000-08-23 |
| CA2123804A1 (fr) | 1993-06-10 |
| HU9401689D0 (en) | 1994-09-28 |
| NO942075D0 (no) | 1994-06-03 |
| DE69232122D1 (de) | 2001-11-15 |
| TW403784B (en) | 2000-09-01 |
| CN1075334A (zh) | 1993-08-18 |
| EP0672157B1 (fr) | 2001-10-10 |
| DE69232122T2 (de) | 2002-05-16 |
| PT672157E (pt) | 2002-04-29 |
| JPH07502403A (ja) | 1995-03-16 |
| ES2163405T3 (es) | 2002-02-01 |
| MX9206981A (es) | 1994-08-31 |
| FI942623A0 (fi) | 1994-06-03 |
| ATE206762T1 (de) | 2001-10-15 |
| IL104003A0 (en) | 1993-05-13 |
| KR950700421A (ko) | 1995-01-16 |
| AU674134B2 (en) | 1996-12-12 |
| KR100272419B1 (ko) | 2001-02-01 |
| NZ246276A (en) | 1996-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE05138B1 (et) | Rekombinantne MVA viirus ja selle kasutamine, isoleeritud eukarootne rakk, meetod rekombinantse HIV Nef-proteiini valmistamiseks ning vaktsiin | |
| RU94038050A (ru) | Рекомбинантный вирус, вектор, вакцина, способ иммунизации, клетка-хозяин | |
| ATE115187T1 (de) | Poxvirus-vektoren. | |
| NO20052149L (no) | Polynukleotidvaksine omfattende sekvens som koder for hepatitt C-virus protein. | |
| DK0437604T3 (da) | Rekombinant poxvirus- og streptokok M-proteinvaccine | |
| NO177716C (no) | Fremgangsmåte for fremstilling av terapeutisk aktive polypeptider, DNA-sekvens, ekspresjonsvektor og antistoff | |
| UA82998C2 (ru) | Экспрессия генов в модифицированном вирусе коровьей оспы ankara с использованием коровьего поксвирусного промотора аті | |
| DK0652287T3 (da) | Poxvirale vektorer og deres anvendelse som en vaccine mod felin infektiøs peritonotos-virussygdom | |
| ES2130189T3 (es) | Vacunas de virus sincitial respiratorio (rsv) mutante que contienen dicho virus y procedimientos de uso. | |
| NO954135D0 (no) | Fiskebukspyttkjertel-sykdomsvirus | |
| SE9903031D0 (sv) | Peptide mixture and vaccine against a chronic viral infection | |
| HUP9901005A2 (hu) | Herpeszvírusok RFHV/KSHV-alcsaládjába tartozó vírusokból származó glikoprotein-B | |
| NO942075L (no) | Rekombinante virus omfattende kunstig proteolytisk spaltingssete | |
| NO964874L (no) | Fusjonsglykoprotein fra HCMV og HSV | |
| BR0310020A (pt) | Expressão de genes no vìrus da vacìnia modificado ancara por uso do promotor de ati de vacìnia | |
| ATE341339T1 (de) | Zusammensetzungen von rekombinanten papillomavirus vakzinen | |
| DK0491713T3 (da) | Rubella El-peptider og C-peptider | |
| FI923020A (fi) | Inte a inte b-sekvenser. | |
| DE69428984D1 (de) | Stimulierung der immunantwort durch virales protein | |
| RU95109909A (ru) | Способ ингибирования ретровирусной инфекции, ингибитор протеазы, кодирующая его нуклеиновая кислота и способ рекомбинантного продуцирования серинового ингибитора | |
| RU94030478A (ru) | Рекомбинантный вирус, способ его получения, способ иммунизации, способ получения протеина, вакцинная композиция, применение рекомбинантного вируса | |
| WO1992014818A3 (fr) | Systeme d'expression d'entomopoxvirus comprenant des sequences de spheroïdine ou de thymidine-kinase | |
| IS3511A7 (is) | Fjölpeptíð framleidd með aðferðum líftækninnar, kjarnsýrur sem samsvara þeim, og notkun fjölpeptíðanna sem bóluefnis gegn VHS veiru í fiski |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |